WE SELL NOTHINGEVERY CLAIM → A PRIMARY SOURCEUNKNOWN IS A REAL ANSWERNO PRODUCTS · NO PROTOCOLS · NO VENDORSWE SELL NOTHINGEVERY CLAIM → A PRIMARY SOURCEUNKNOWN IS A REAL ANSWER
Source record · FDA evidence review · reviewed July 17, 2026

The best-described large obesity study in FDA's review was negative.

Misleading
The circulating claim

“AOD-9604 is clinically proven to burn fat without the usual growth-hormone effects.”

What the source record says

FDA's evidence review found a lack of support for effectiveness in obesity. The largest identified study enrolled 536 people and found no significant weight-loss difference from placebo at 12 weeks.

A proposed mechanism and early development story are being presented as if a large controlled clinical outcome were positive.

The best-described large obesity study in FDA's review was negative.

FDA AOD-9604 briefing documentOpen source ↗AOD-9604 library entryOpen source ↗
What changed

Added the source-verified Claim Check to the structured claim/source/change registry.

What would change our answer

A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.

Version history · 1 entry
  1. v1 · 2026-07-17Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.